On Sunday, April 20th 2025, starting 8:30am GMT, there will be maintenance work that will involve the website being unavailable during parts of the day. We apologize for any inconvenience this may cause and appreciate your understanding.
We noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
- View the Talks
-
1. The mononuclear phagocyte system: tissue resident macrophages - activation and regulation
- Prof. Emeritus Siamon Gordon
-
2. Biosimilars: when value meets cost
- Prof. Fernando de Mora
-
3. Mononuclear phagocytes - origins, fates and functions
- Prof. Steffen Jung
-
4. Transcription factors in macrophage differentiation
- Dr. Michael Sieweke
-
5. Fetal macrophages
- Prof. Paul Martin
-
6. The alveolar macrophage
- Dr. Ronald G. Crystal
-
7. Airway macrophages in health and disease
- Prof. Tracy Hussell
-
8. Intestinal macrophages - heterogeneity, origins and functions
- Prof. Allan Mowat
-
9. Osteoclasts: what do they do and how do they do it?
- Prof. Steven L. Teitelbaum
-
10. The biology of Fc receptors and complement receptors
- Prof. Steven Greenberg
-
12. Tumour-associated macrophages
- Prof. Michele De Palma
- Dr. Mario Squadrito
-
13. The recognition of pathogens by C-type lectins
- Prof. Gordon D. Brown
-
14. Macrophage phagocytosis
- Prof. Joel Swanson
-
15. Macrophage CD36 and atherosclerosis
- Dr. Maria Febbraio
-
16. Toll-Like receptor signaling and the innate immune response
- Dr. Kate Fitzgerald
-
17. Innate immune receptors as mediators of systemic inflammation and pathogenesis of malaria
- Prof. Ricardo Gazzinelli
-
19. Triggering receptors expressed on myeloid cells (TREM)
- Dr. Daniel W. McVicar
-
20. Influence of eicosanoid lipid mediators on macrophage innate immune functions
- Prof. Marc Peters-Golden
-
21. Macrophage paired receptor interactions
- Prof. Neil Barclay
-
22. Macrophage heterogeneity in atherosclerosis regression
- Prof. Edward Fisher
-
23. Gaucher disease: from lysosomal storage to immunopathology
- Prof. Johannes M.F.G. Aerts
-
24. Macrophage in asthma
- Prof. Douglas Robinson
-
25. The macrophage mannose receptor
- Dr. Luisa Martinez-Pomares
-
26. Myeloid-derived suppressor cells in cancer
- Prof. Dmitry Gabrilovich
-
27. EGF-TM7 receptors
- Dr. Jörg Hamann
- Dr. Hsi-Hsien Lin
-
28. Macrophages in helminth infection
- Prof. Judith Allen
- Archived Lectures *These may not cover the latest advances in the field
-
29. Immunosuppressive mechanisms in myeloid cells
- Prof. Dmitry Gabrilovich
Printable Handouts
Navigable Slide Index
- Introduction
- Lecture outline
- Macrophages - general attributes
- Macrophages and receptor recognition
- CD36 structure
- CD36: regions within the protein
- CD36: function and membrane distribution
- CD36: a multifunctional membrane glycoprotein (1)
- CD36: a multifunctional membrane glycoprotein (2)
- Atherogenesis and monocytes/macrophages
- A tale of two mice
- Experimental design of atherosclerosis in mice
- The aortic tree in mice and humans
- Absence of CD36 & atherosclerosis in apoEo mice
- ApoEo vs. ApoEo/CD36o: degree of lesions
- Lesions in LDLRo mice are not CD36 dependent
- LDLRo vs. LDLRo/CD36o lesion burden
- Foam cell formation in LDLRo is CD36 dependent
- CD36 may not be the atherogenic ligand in LDLRo
- In vivo foam cell assay
- The ligand in the 2 mouse models differs
- Ligand may differ in a CD36 dependent manner
- Making the LDL in the LDLRo a ligand for CD36
- LDLRo vs. CD36o/LDLRo + high cholesterol diet
- LDLR KO's: hyperlipidemia and inflammation
- Inflammation, CD36 ligands and atherosclerosis
- CD36 specific ligands in oxidatively modified LDL
- CD36 ligands are choline glycerophospholipids
- How CD36 detects differences in phospholipids
- Multiple pathways may create CD36R ligands
- Recognition of altered self ligands by CD36
- Summary
- Acknowledgements
Topics Covered
- Scavenger receptors
- Structure of CD36
- Role of CD36
- The link between inflammation and CD36
- Risk factors for inflammation
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
Febbraio, M. (2013, January 30). Macrophage CD36 and atherosclerosis [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved April 19, 2025, from https://doi.org/10.69645/LVLM9718.Export Citation (RIS)
Publication History
- Published on January 30, 2013
Financial Disclosures
- Dr. Maria Febbraio has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.